Annual Pricing, Reimbursement & Market Access in Pharma 2013

FIND YOUR REASONS TO ATTEND
Pharmaceutical pricing, reimbursement and market access systems differ significantly in the European countries and are regularly subject to change. Our aim is to provide an overview about pharmaceutical pricing and reimbursement policies, their application, obstacles and opportunities within the industry and national systems. Reference pricing initiatives applied to innovative drugs, austerity measures influence on healthcare delivery and long market access periods present challenges, which can be more managable by multi-stakeholders discussions in a highly proactive environment. Following seven successful annual events, Fleming Europe invites you to the 8th Annual Pricing, Reimbursement & Market Access in Pharma.


KEY TOPIC

-Explore the latest developments in P&R in key European Pharma markets
-Understand the changing regulatory environment and discuss further progress
-Reveal innovative risk-sharing schemes in practice
-Gain insights into the payers‘ and decisionmakers‘ needs
-Learn how to balance costs with innovation
-Discover growth solutions to remain competitive
-Obtain information about how to deliver the right treatment to the right patient at the right time
-Benefit from enhancing cooperation with HTAs, Academia and Payers
-PLUS – interactive BREAK-OUT sessions & discussions